Catalent Pharma Solutions 4Q Revenues: $451.3 million (+5%) 4Q Loss: $168.7 million (earnings were $27.6 million 4Q2006) FY Revenues: $1.7 billion (+6%) FY Loss: $127.3 million (earnings were $51 million FY2006) Comments: FY and 4Q revenue growth was primarily driven by the Packaging Services segment, particularly within Europe, as well as from continued strong demand for Zydis products within the Oral Technologies segment. Packaging Services revenue was $138 million in the quarter, up...